Behçet's disease associated with superior vena cava syndrome without thrombosis

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 804-806

  de Paiva Jr , Tadeu Ferreira ^a   Ribeiro, Henrique Barbosa ^a,c   Campanholo, Cristiano Barbosa ^a   Gonçalves, Célio Roberto ^b   Terigoe, Dawton Y ^a   Souza, Branca Dias Batista ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Beh et's disease; Superior vena cava syndrome; Thrombosis; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; HEPARIN; PREDNISOLONE; PREDNISONE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CASE REPORT; CEPHALIC VEIN; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FOLLOW UP; HUMAN; HYPERCOAGULABILITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SUPERIOR CAVA VEIN SYNDROME; THORAX RADIOGRAPHY; VEIN THROMBOSIS; VEIN WALL;

ADULT; BEHCET SYNDROME; HUMANS; MALE; SUPERIOR VENA CAVA SYNDROME;

EID: 34147124296     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0241-2     Document Type: Article

References (16)

1. Aksu K, Kabasakal Y, Sayiner A et al (1999) Prevalences of hepatitis A, B, C and E viruses in Behçet's disease. Rheumatology 38(12):1279-1281
2. Benezra D, Hamuryudan V, Sonsuz A et al (1995) More on hepatitis C virus and Behçet's syndrome. [Letter]. Munke H, Stockmann F, Ramadori G [reply]. N Engl J Med 333:322-323
3. Calamia KT, Schirmer M, Melikoglu M (2005) Major vessel involvement in Behcet disease. Curr Opin Rheumatol 17(1):1-8
4. Chen JC, Bongard F, Klein SR (1990) A contemporary perspective on superior vena cava syndrome. Am J Surg 160:207-211
5. de Jesus H, Rosa M, Queiroz MV (1997) Vascular involvement in Behcet's disease. An analysis of twelve cases. Clin Rheumatol 16(2):220-221
6. Ehrlich GE (1997) Vasculitis in Behçet's disease. Int Rev Immunol 14:81-88
7. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I (2000) Epidemiologic and clinical aspects of Behcet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol 27(3):703-707
8. Heyman RE, Ferraz MB, Goncalves CR, Atra E (1995) Evaluation of the International Study Group for Behcet's Disease Criteria in Brazilian patients. Clin Rheumatol 14(5):526-530
9. Ilter N, Senol E, Gurer MA, Oztas MO (2000) Behçet's disease and HCV infection. Int J Dermatol 39(5):396-397
10. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
11. Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet's disease - an update. Semin Arthritis Rheum 30(5):299-312
12. Koç Y, Güllü I, Gorgün A et al (1992) Vascular involvement in Behçet's disease. J Rheumatol 19:402-410
13. Kuzu MA, Ozastan C, Koksoy C, Gurler A, Tuzuner A (1994) Vascular involvement in Behçet's disease: 8-year audit. World J Surg 18:948-953
14. Roguin A, Edelstein S, Edoute Y (1997) Superior vena cava syndrome as a primary manifestation of Behçet's disease. Angiology 48:365-368
15. Schneider DT, Jorizzo JL (1987) Behçet disease and complex aphthosis. Dermatol Clin 5:760-778
16. Terzioglu E, Kirmaz C, Uslu R, Sin A, Kokuludag A, Sagduyu A, Uzunel H, Sebik F, Kabakci T (1998) Superior vena cava syndrome together with multiple venous thrombosis in Behcet's disease. Clin Rheumatol 17(2):176-177